COPD phenotypes in a lung cancer screening population

Clinical Respiratory Journal

Volumn 10, Issue 1, 2016, Pages 48-53

  Balkan, Arzu ^a   Bulut, Yonca ^b   Fuhrman, Carl R ^c   Fisher, Stephen N ^c   Wilson, David O ^c   Weissfeld, Joel L ^c   Sciurba, Frank C ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Computed tomography; Pulmonary function tests

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASYMPTOMATIC DISEASE; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; EMPHYSEMA; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY; SYMPTOM; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG FUNCTION TEST; LUNG NEOPLASMS; MIDDLE AGED; PENNSYLVANIA; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PENNSYLVANIA; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; SMOKING; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84953835834     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12180     Document Type: Article

References (47)

1. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care. 2003;48(12): 1185-1193.
2. Han MK, Agusti A, Calverley PM, etal. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5): 598-604.
3. Garcia-Aymerich J, Agustí A, Barberà JA, etal. Phenotypic heterogeneity of chronic obstructive pulmonary disease. Arch Bronconeumol. 2009;45(3): 129-138.
4. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48(3): 86-98.
5. National Lung Screening Trial Research Team, Aberle DR, Adams AM, etal. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5): 395-409.
6. White CS. National Lung Screening Trial: a breakthrough in lung cancer screening? J Thorac Imaging. 2011;26(2): 86-87.
7. Zheng B, Leader JK, Coxson HO, etal. CT acquisition technique and quantitative analysis of the lung parenchyma: variability and corrections. Proc SPIE. 2006;6143: 2S-1-220108.
8. Wilson DO, Weissfeld JL, Balkan A, etal. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7): 738-744.
9. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117(4): 1146-1161.
10. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5): 1202-1218.
11. Global Initiative for Chronic Obstructive Lung Disease. GOLD guidelines at-a-glance desk reference. Available at: http://www.goldcopd.org (accessed 10 January 2008).
12. Department of Health and Human Services National Institutes of Health National Heart, LKung, and Blood Institute. National Emphysema Treatment Trial. Available at: http://www.nhlbi.nih.gov/health/prof/lung/nett/lvrsweb.htm, 2003.
13. Diamant Z, Tarasevych S, Clarke GW. New and existing pharmacotherapeutic options for persistent asthma and COPD. Neth J Med. 2011;69(11): 486-499.
14. Kim V, Han MK, Vance GB, etal. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3): 626-633.
15. Müller NL, Coxson H. Chronic obstructive pulmonary disease. 4: imaging the lungs in patients with chronic obstructive pulmonary disease. Thorax. 2002;57(11): 982-985.
16. Bafadhel M, Umar I, Gupta S, etal. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3): 634-642.
17. Han MK, Bartholmai B, Liu LX, etal. Clinical significance of radiologic characterizations in COPD. COPD. 2009;6(6): 459-467.
18. Reilly J. Using computed tomographic scanning to advance understanding of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(5): 450-455.
19. Friedman PJ. Imaging studies in emphysema. Proc Am Thorac Soc. 2008;5(4): 494-500.
20. Kauczor HU, Wielpütz MO, Owsijewitsch M, Ley-Zaporozhan J. Computed tomographic imaging of the airways in COPD and asthma. J Thorac Imaging. 2011;26(4): 290-300.
21. Coxson HO. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(9): 940-945.
22. Coxson HO, Lam S. Quantitative assessment of the airway wall using computed tomography and optical coherence tomography. Proc Am Thorac Soc. 2009;6(5): 439-443.
23. Matsuoka S, Yamashiro T, Washko GR, Kurihara Y, Nakajima Y, Hatabu H. Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics. 2010;30(1): 55-66.
24. Mets OM, de Jong PA, van Ginneken B, Gietema HA, Lammers JW. Quantitative computed tomography in COPD: possibilities and limitations. Lung. 2012;190(2): 133-145.
25. Washko GR, Criner GJ, Mohsenifar Z, etal. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD. 2008;5(3): 177-186.
26. Ward SA, Casaburi R. 21st century perspective on chronic obstructive pulmonary disease. Respiration. 2001;68(6): 557-561.
27. Siafakas NM, Tzortzaki EG. Few smokers develop COPD. Why? Respir Med. 2002;96(8): 615-624.
28. Ferguson GT. Management of COPD. Early identification and active intervention are crucial. Postgrad Med. 1998;103(4): 129-134, 136-41.
29. Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, Sobaszek A. Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology. 2002;222(1): 261-270.
30. Clark KD, Wardrobe-Wong N, Elliott JJ, Gill PT, Tait NP, Snashall PD. Patterns of lung disease in a 'normal' smoking population: are emphysema and airflow obstruction found together? Chest. 2001;120(3): 743-747.
31. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124(2): 474-481.
32. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435): 709-721.
33. Berger P, Laurent F, Begueret H, etal. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology. 2003;228(1): 85-94.
34. Hogg JC, Chu F, Utokaparch S, etal. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26): 2645-2653.
35. Agusti A, Calverley PM, Celli B, etal. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(122): 1-14.
36. Boschetto P, Miniati M, Miotto D, etal. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J. 2003;21(3): 450-454.
37. Sashidhar K, Gulati M, Gupta D, Monga S, Suri S. Emphysema in heavy smokers with normal chest radiography. Detection and quantification by HCRT. Acta Radiol. 2002;43(1): 60-65.
38. Seaton D, Ogilvie CM. Regional lung function in asymptomatic cigarette smokers. Am Rev Respir Dis. 1978;118(2): 265-270.
39. Colp C, Park SS, Williams MH Jr. Emphysema with little airway obstruction. Am Rev Respir Dis. 1970;101(4): 615-619.
40. Tanaka N, Matsumoto T, Miura G, etal. Air trapping at CT: high prevalence in asymptomatic subjects with normal pulmonary function. Radiology. 2003;227(3): 776-785.
41. Klein JS, Gamsu G, Webb WR, Golden JA, Müller NL. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology. 1992;182(3): 817-821.
42. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990;84(5): 365-369.
43. Márquez-Martín E, Ramos PC, López-Campos JL, etal. Components of physical capacity in patients with chronic obstructive pulmonary disease: relationship with phenotypic expression. Int J Chron Obstruct Pulmon Dis. 2011;6: 105-112.
44. Marsh SE, Travers J, Weatherall M, etal. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9): 761-767.
45. Dosman J, Bode F, Ghezzo RH, Martin R, Macklem PT. The relationship between symptoms and functional abnormalities in clinically healthy cigarette smokers. Am Rev Respir Dis. 1976;114(2): 297-304.
46. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 2003;254(6): 540-547.
47. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2): 347-360.